R&D How to transition from lab to commercial-scale ATMP Manufact... This is the first article of our series, “The ATMP Manufacturer’s Guide to Commercialisation and cGMP Compliance”.
Partner Content Partner Content Exclusive Speaker Interview for SMI’s Inaugural Cell & G... Speaker Interview for Cell & Gene Therapy 2018
News Gene therapy trials held back by fragmented EU rules Biotech and pharma organisations are calling for EU countries to harmonise regulations, or otherwise face falling behind in cutting-edge gene and cell therapy trials.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
